Ozone Exposure for Acute Lung Injury
(LOCONOZ2 Trial)
Trial Summary
What is the purpose of this trial?
Purpose: The primary purpose of this study is to measure pulmonary function, symptoms, and pulmonary inflammatory responses in healthy young adults during and immediately after exposure to a low concentration of ozone (0.070 ppm) or clean air for 6.6 hours while undergoing moderate intermittent exercise. This concentration is the current EPA NAAQS standard for ozone.
Do I need to stop taking my current medications to join the trial?
Yes, you may need to stop taking certain medications. The trial excludes participants taking mega doses of vitamins, supplements, homeopathic/naturopathic medicines, or medications that may impact the ozone challenge results, including systemic steroids and beta blockers. Other medications not mentioned may be reviewed by investigators before inclusion.
What data supports the idea that Ozone Exposure for Acute Lung Injury is an effective treatment?
The available research does not support the idea that ozone exposure is an effective treatment for acute lung injury. In fact, the studies suggest that exposure to ozone, especially at higher concentrations, can lead to negative effects on lung function. For example, one study found that exposure to 0.40 ppm ozone resulted in a significant reduction in lung function, and another study showed that elite cyclists experienced impaired exercise performance and lung function at 0.20 ppm ozone. These findings indicate that ozone exposure may actually worsen lung conditions rather than improve them.12345
What safety data exists for ozone exposure in treating acute lung injury?
The safety data for ozone exposure, particularly at concentrations like 0.070 ppm, includes studies on pulmonary function and subjective symptoms during exercise. Research indicates that ozone exposure can lead to significant decrements in lung function, such as reduced forced expiratory volume (FEV1), and can cause respiratory discomfort, including cough and shortness of breath. These effects are observed both in controlled laboratory settings and in ambient air conditions. The impact of ozone is influenced by exercise intensity, with higher minute ventilation during exercise increasing ozone inhalation and potentially enhancing its effects. However, studies show that similar pulmonary function effects occur with both intermittent and continuous exercise at equivalent ozone doses. Additionally, factors like obesity may exacerbate ozone-induced airway reactivity and inflammation. Overall, the data suggests that while ozone exposure can impair lung function and cause discomfort, the severity of these effects can vary based on individual characteristics and exercise conditions.36789
Is the treatment 'Exposure to 0.070 ppm Ozone Concentration, Moderate Intermittent Exercise' promising for acute lung injury?
The treatment of moderate intermittent exercise with exposure to 0.070 ppm ozone concentration is not promising for acute lung injury. Research shows that ozone exposure can impair lung function and cause discomfort, even at low levels. While intermittent exercise might reduce some symptoms compared to continuous exercise, the overall impact on lung function remains negative.278910
Research Team
Andy Ghio, M.D.
Principal Investigator
EPA/ORD/CPHEA/PHITD/CRB
Eligibility Criteria
Healthy adults aged 18-35 with normal lung function and the ability to do moderate exercise for 6.6 hours can join this trial. Pregnant women, smokers, those with asthma or recent respiratory illness, uncontrolled hypertension, or not up-to-date on COVID vaccines are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Exposure
Participants are exposed to either clean air or 0.070 ppm ozone for 6.6 hours while performing moderate intermittent exercise
Immediate Post-Exposure Assessment
Pulmonary function and inflammatory responses are measured immediately after exposure
Follow-up
Participants are monitored for changes in neutrophil levels and lung function 18 hours post-exposure
Treatment Details
Interventions
- Exposure to 0.070 ppm Ozone Concentration
- Exposure to Clean Air (0.0 ppm Ozone)
- Moderate Intermittent Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Martin W. Case
Lead Sponsor
University of North Carolina
Collaborator